Responsibility for claims in these press releases rests with the companies issuing them. We make these press releases available for your information.
Selection is incomplete and often late.
By including, we do not intend to recommend. Research Emphasizing Low-Dose Cancer Therapy Featured at Annual Meeting of American Association for Cancer Research. Issued April 4, 1999. Issued January 20. 1999. Genzyme Molecular Oncology Announces Previously Undisclosed Antiangiogenic Compound.